Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients
This is a survey study to evaluate the feasibility and effectiveness of an affordable, $400 flat rate, same-day consultation, simulation, and delivery of a single fraction of palliative radiation therapy for patients with symptomatic bony metastatic disease who are currently enrolled in hospice. Treatment planning and delivery of palliative radiotherapy will utilize "standard of care" techniques.
Checked against the public recordLast updated Feb 29, 2016 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Virginia Commonwealth University
- Interventions being studied
- Radiation: Radiation Therapy; Other: Quality-of-Life Assessment; Other: Survey Administration
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Symptomatic osseous bone lesion(s) from any malignancy, whether primary of metastatic, with histological confirmation of malignancy. * Currently enrolled in hospice and referred for single fraction palliative radiotherapy. * Performance status (to be evaluated by the radiation oncologist), Karnofsky Performance Scale ≥ 20 or ECOG Performance Scale \< 5 . * Ability to understand and willingness to sign a written informed consent document Exclusion Criteria: * Pregnancy. * Unable to understand English. * Unable to complete forms with assistance. * Concurrent enrollment in a study of pain management involving medications or devices.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Virginia Commonwealth University/Massey Cancer CenterRichmond, Virginia
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 29, 2016. Always confirm current availability with the study team.